Code availability
Not applicable.
References
Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430
Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414. https://doi.org/10.1056/NEJMra1206793
Li X, Ma J, Zhao Y, Wang HY, Li XM (2015) Development of crescentic immunoglobulin a nephritis and multiple autoantibodies in a patient during adalimumab treatment for rheumatoid arthritis. Chin Med J (Engl) 128:2555–2556. https://doi.org/10.4103/0366-6999.164992
Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D’Agati VD (2005) Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 20:1400–1406. https://doi.org/10.1093/ndt/gfh832
Wendling D, Humbert P, Hory B, Blanc D, Dupond JL, Guidet M (1989) The kidney in Still’s disease in adults. Rev Rhum Mal Osteoartic 56:325–327
Toussirot E, Aubin F (2016) Paradoxical reactions under TNF-alpha blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open 2:e000239. https://doi.org/10.1136/rmdopen-2015-000239
Su H, Lei CT, Zhang C (2017) Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol 8:405. https://doi.org/10.3389/fimmu.2017.00405
Taniguchi Y, Yorioka N, Kumagai J, Katsutani M, Kuratsune M, Amimoto D, Yamakido M (1999) Interleukin-6 localization and the prognosis of IgA nephropathy. Nephron 81:94–98. https://doi.org/10.1159/000045254
Funding
No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has declared no conflicts of interest.
Informed consent
The patient has given written consent to publish his personal and medical information for the publication of the case report.
Consent to participate
Informed consent was obtained from the patient, and the patient consent declaration form has been provided.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kang, JH. IgA nephropathy in adult-onset Still’s disease after tocilizumab treatment: a case report. Int Urol Nephrol 54, 1167–1168 (2022). https://doi.org/10.1007/s11255-021-02956-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02956-x